Michael Okunewitch

Stock Analyst at Maxim Group

(0)
# 5042
Out of 5,356 analysts
28
Total ratings
31.82%
Success rate
-32.22%
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
HCWB HCW Biologics
Maintains: Buy
120 35
5.95 488.24% 2 May 29, 2025
CTOR Citius Oncology
Downgrades: Hold
n/a
n/a n/a 2 May 23, 2025
ANEB Anebulo Pharmaceutic...
Maintains: Buy
6 3
1.12 167.86% 2 May 15, 2025
RADX Radiopharm Theranost...
Initiates Coverage On: Buy
12
5.18 131.66% 1 May 1, 2025
CMMB Chemomab Therapeutic...
Maintains: Strong Buy
4 7
1.31 434.35% 2 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
2 600% 1 Feb 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 3
0.66 354.55% 1 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
0.95 321.05% 1 Oct 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
0.83 1345.78% 1 Sep 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 6
1.18 408.47% 2 Aug 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
3 12
1 1100% 2 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
2
n/a n/a 1 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
1.25 1820% 1 Oct 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
108 18
3.09 482.52% 3 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
2025
n/a n/a 1 Apr 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
21.67 15.37% 1 Dec 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.79 235.2% 1 Sep 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
120
n/a n/a 1 Feb 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
2.46 916.26% 1 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
100
0.83 11948.19% 1 Nov 30, 2021